Here, we report that the S1 subunit of the SARS-CoV-2 S protein has superiority over the receptor-binding domain (RBD) and the native state S trimer in terms of sensitivity and specificity, respectively, in measuring anti-SARS-CoV-2 antibodies from COVID-19 convalescent patients. The gene discussed is PROS1; the disease is COVID-19.